Lineage Cell Therapeutics Inc (LCTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.26B
EV to revenue ratio (TTM)
17.17
EV to ebitda
-8.84
Financial Performance
Revenue (TTM)
$0.01B
Gross profit (TTM)
-$0.01B
EBITDA
-$0.03B
Profitability
Operating margin (TTM)
-835.00%
Profit margin
-246.60%
Return on assets (TTM)
-17.00%
Return on equity (TTM)
-60.10%
Per Share Metrics
Revenue per share (TTM)
$0.05
EPS
-$0.20
Diluted EPS (TTM)
-$0.20
Book value
$0.24
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
30.67
PEG ratio
10.64
Price to sales ratio (TTM)
20.10
Price to book ratio (TTM)
4.48
Growth
Quarterly earnings growth (YoY)
-61.30%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
5
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.69